U.S. FDA delays decision on Juul e-cigarettes

(Reuters) - The U.S. Food and Drug Administration said on Thursday it needs more time to decide whether e-cigarette maker Juul Labs Inc and other major manufacturers can sell their products in the United States.

The agency had been expected to make a decision by Thursday, a year after Juul and other e-cigarette brands, including British American Tobacco Plc's Vuse and Imperial Brands Plc's Blu, faced a deadline to file applications showing their products provided a net benefit to public health.

The agency said on Thursday that it continues to "work expeditiously on the remaining applications," adding many are "in the final stages of review."

(Reporting by Ankur Banerjee in Bengaluru and Chris Kirkham in Los Angeles; Editing by Shailesh Kuber)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
• Keenova doses first patient in Phase 3 hammer toe drug trial
• FDA grants accelerated approval to Ultragenyx gene therapy for GSDIa